PE20000537A1 - Composicion farmaceutica dispersable que contiene antagonistas de sustancia p de piperidina - Google Patents
Composicion farmaceutica dispersable que contiene antagonistas de sustancia p de piperidinaInfo
- Publication number
- PE20000537A1 PE20000537A1 PE1999000436A PE00043699A PE20000537A1 PE 20000537 A1 PE20000537 A1 PE 20000537A1 PE 1999000436 A PE1999000436 A PE 1999000436A PE 00043699 A PE00043699 A PE 00043699A PE 20000537 A1 PE20000537 A1 PE 20000537A1
- Authority
- PE
- Peru
- Prior art keywords
- weight
- substance
- antagonist
- fatty acid
- oil
- Prior art date
Links
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 title abstract 4
- 239000003890 substance P antagonist Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- -1 POLYOXYETHYLENE Polymers 0.000 abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 2
- 239000000194 fatty acid Substances 0.000 abstract 2
- 229930195729 fatty acid Natural products 0.000 abstract 2
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 abstract 1
- WZKSXHQDXQKIQJ-UHFFFAOYSA-N F[C](F)F Chemical group F[C](F)F WZKSXHQDXQKIQJ-UHFFFAOYSA-N 0.000 abstract 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 abstract 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000003169 central nervous system Anatomy 0.000 abstract 1
- 239000007795 chemical reaction product Substances 0.000 abstract 1
- 235000005687 corn oil Nutrition 0.000 abstract 1
- 239000002285 corn oil Substances 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 239000002105 nanoparticle Substances 0.000 abstract 1
- 239000003921 oil Substances 0.000 abstract 1
- 235000019198 oils Nutrition 0.000 abstract 1
- 239000002245 particle Substances 0.000 abstract 1
- 230000000241 respiratory effect Effects 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
- 230000002269 spontaneous effect Effects 0.000 abstract 1
- 239000001069 triethyl citrate Substances 0.000 abstract 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 abstract 1
- 235000013769 triethyl citrate Nutrition 0.000 abstract 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 abstract 1
- 235000015112 vegetable and seed oil Nutrition 0.000 abstract 1
- 239000008158 vegetable oil Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
- A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Dispersion Chemistry (AREA)
- Psychiatry (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Pain & Pain Management (AREA)
- Hospice & Palliative Care (AREA)
- Immunology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
SE REFIERE A UNA COMPOSICION QUE SE PUEDE DISPERSAR DE UNA MANERA ESPONTANEA Y COMPRENDE a)0,05% A 20% EN PESO DE UN ANTAGONISTA DE SUSTANCIA P DE PIPERIDINA TAL COMO (2R,4S)-N-(1-(3,5-BIS(TRIFLUOROMETIL)-BENZOIL)-2-(4-CLOROBENCIL)-4-PIPERIDINIL)-QUINOLIN-4-CARBOXAMIDA Y b)UN MEDIO PORTADOR QUE COMPRENDE i)DE 5% A 50% EN PESO DE UN COMPONENTE HIDROFILICO TAL COMO CITRATO DE TRIETILO, PROPILENGLICOL; ii)DE 5% A 80% EN PESO DE UN TENSOACTIVO TAL COMO UN PRODUCTO DE REACCION DE UN ACEITE DE RICINO NATURAL O HIDROGENADO CON OXIDO DE ETILENO O UN ESTER DE ACIDO GRASO DE POLIOXIETILENO; iii)DE 5% A 85% EN PESO DE UN COMPONENTE LIPOFILICO TAL COMO ACEITE VEGETAL ETOXILADO TRANSESTERIFICADO, MONO-, DI-, TRIGLICERIDO DE ACIDO GRASO C8-C10, ACEITE DE MAIZ TRANSESTERIFICADO CON GLICEROL REFINADO. LA COMPOSICION SE CARACTERIZA POR LA FORMACION DE ESTRUCTURAS COLOIDALES DE PARTICULAS SOLIDAS O LIQUIDAS EN FORMA DE GOTAS O NANOPARTICULAS O ESTRUCTURAS MICELARES DE HASTA 1000 NANOMETROS DE DIAMETRO AL PONERSE EN CONTACTO CON UN MEDIO ACUOSO PRESENTANDOSE COMO UN PRECONCENTRADO DE MICROEMULSION. EL ANTAGONISTA DE LA SUSTANCIA P PUEDE SER UTIL PARA EL TRATAMIENTO DE DESORDENES DEL SISTEMA NERVIOSO CENTRAL, ENFERMEDADES RESPIRATORIAS
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811200.6A GB9811200D0 (en) | 1998-05-26 | 1998-05-26 | Organic compounds |
| GBGB9818105.0A GB9818105D0 (en) | 1998-08-19 | 1998-08-19 | Organic compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20000537A1 true PE20000537A1 (es) | 2000-07-10 |
Family
ID=26313736
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1999000436A PE20000537A1 (es) | 1998-05-26 | 1999-05-25 | Composicion farmaceutica dispersable que contiene antagonistas de sustancia p de piperidina |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20020156099A1 (es) |
| EP (1) | EP1082119B1 (es) |
| JP (1) | JP4083985B2 (es) |
| KR (1) | KR20010043669A (es) |
| CN (1) | CN1270714C (es) |
| AR (1) | AR018376A1 (es) |
| AT (1) | ATE257380T1 (es) |
| AU (1) | AU755134B2 (es) |
| BE (1) | BE1012143A5 (es) |
| BR (1) | BR9910696A (es) |
| CA (1) | CA2333154C (es) |
| DE (2) | DE69914077T2 (es) |
| DK (1) | DK1082119T3 (es) |
| ES (1) | ES2214859T3 (es) |
| FR (1) | FR2779145B1 (es) |
| GB (1) | GB2353473A (es) |
| HU (1) | HUP0102202A3 (es) |
| ID (1) | ID27096A (es) |
| IL (1) | IL139501A0 (es) |
| IT (1) | IT1313551B1 (es) |
| NO (1) | NO20005920L (es) |
| NZ (1) | NZ508325A (es) |
| PE (1) | PE20000537A1 (es) |
| PL (1) | PL344245A1 (es) |
| PT (1) | PT1082119E (es) |
| RU (1) | RU2240121C2 (es) |
| SK (1) | SK17752000A3 (es) |
| TR (1) | TR200003502T2 (es) |
| TW (1) | TW537894B (es) |
| WO (1) | WO1999061025A1 (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR018376A1 (es) | 1998-05-26 | 2001-11-14 | Novartis Ag | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento |
| AU2003225260A1 (en) * | 2002-04-22 | 2003-11-03 | University Of Florida | Microemulsions for selective molecular separation |
| GB0220953D0 (en) * | 2002-09-10 | 2002-10-23 | Novartis Ag | Organic compounds |
| US7842791B2 (en) | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| FR2934955B1 (fr) | 2008-08-14 | 2011-07-08 | Commissariat Energie Atomique | Encapsulation d'agents therapeutiques lipophiles ou amphiphiles dans des nanoemulsions |
| FR2934954B1 (fr) | 2008-08-14 | 2011-07-22 | Commissariat Energie Atomique | Emulsion fluorescente de vert d'indocyanine |
| FR2935001B1 (fr) * | 2008-08-14 | 2011-12-30 | Commissariat Energie Atomique | Emulsion fluorescente |
| FR2934953B1 (fr) | 2008-08-14 | 2011-01-21 | Commissariat Energie Atomique | Nanoemulsions de nanocristaux |
| BR112015015788A2 (pt) * | 2012-12-31 | 2017-07-11 | Jrx Biotechnology Inc | formulações farmacêuticas de nano-emulsão tópicas líquidas |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3305689A1 (de) | 1983-02-18 | 1984-08-23 | Mack Chem Pharm | Pharmazeutische zubereitung mit retardwirkung |
| US5342625A (en) * | 1988-09-16 | 1994-08-30 | Sandoz Ltd. | Pharmaceutical compositions comprising cyclosporins |
| MY110227A (en) * | 1991-08-12 | 1998-03-31 | Ciba Geigy Ag | 1-acylpiperindine compounds. |
| DE4220616C2 (de) | 1992-06-24 | 1994-12-22 | Byk Gulden Lomberg Chem Fab | Dexniguldipin zur intravenösen Verabreichung |
| EP0589843B1 (en) | 1992-09-25 | 2001-11-28 | Novartis AG | Pharmaceutical compositions containing cyclosporins |
| GB2278780B (en) * | 1993-05-27 | 1998-10-14 | Sandoz Ltd | Macrolide formulations |
| ATE333867T1 (de) * | 1994-03-18 | 2006-08-15 | Shire Lab Inc | Emulgierte arzneistoffabgabesysteme |
| TW397825B (en) * | 1994-10-14 | 2000-07-11 | Novartis Ag | Aroyl-piperidine derivatives |
| IL129547A (en) * | 1994-10-26 | 2001-01-11 | Novartis Ag | Pharmaceutical compositions comprising a macrolide and an acid |
| GB2308545B (en) | 1994-10-26 | 1999-06-02 | Novartis Ag | Pharmaceutical microemulsion preconcentrates |
| FR2728169A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des prurits et des dysesthesies oculaires ou palpebrales |
| FR2728165A1 (fr) * | 1994-12-19 | 1996-06-21 | Oreal | Utilisation d'un antagoniste de substance p pour le traitement des rougeurs cutanees d'origine neurogene |
| CA2216701A1 (en) * | 1995-03-27 | 1996-10-03 | Akira Okayama | Piperidine derivatives |
| NZ280689A (en) | 1995-12-15 | 1997-08-22 | Bernard Charles Sherma Sherman | Pharmaceutical composition comprising a cyclosporipharmaceutical composition comprising a cyclosporin; a tocol, tocopherol or tocotrienol; and propylen; a tocol, tocopherol or tocotrienol; and propylene carbonate or polyethylene glycol ne carbonate or polyethylene glycol |
| GB9601120D0 (en) | 1996-01-19 | 1996-03-20 | Sandoz Ltd | Organic compounds |
| AU2898297A (en) | 1996-05-24 | 1998-01-05 | Novartis Ag | Use of substance p antagonists for treating social phobia |
| AR018376A1 (es) | 1998-05-26 | 2001-11-14 | Novartis Ag | Composiciones farmaceuticas que se pueden dispersar de una manera espontanea y el uso de las mismas para la manufactura de un medicamento |
-
1999
- 1999-05-24 AR ARP990102454A patent/AR018376A1/es not_active Application Discontinuation
- 1999-05-24 TW TW088108449A patent/TW537894B/zh not_active IP Right Cessation
- 1999-05-25 PE PE1999000436A patent/PE20000537A1/es not_active Application Discontinuation
- 1999-05-25 BE BE9900364A patent/BE1012143A5/fr not_active IP Right Cessation
- 1999-05-26 PT PT99927760T patent/PT1082119E/pt unknown
- 1999-05-26 IL IL13950199A patent/IL139501A0/xx unknown
- 1999-05-26 AT AT99927760T patent/ATE257380T1/de not_active IP Right Cessation
- 1999-05-26 KR KR1020007012871A patent/KR20010043669A/ko not_active Ceased
- 1999-05-26 DE DE69914077T patent/DE69914077T2/de not_active Expired - Lifetime
- 1999-05-26 RU RU2000133308/15A patent/RU2240121C2/ru not_active IP Right Cessation
- 1999-05-26 CA CA002333154A patent/CA2333154C/en not_active Expired - Fee Related
- 1999-05-26 PL PL99344245A patent/PL344245A1/xx unknown
- 1999-05-26 CN CNB998066036A patent/CN1270714C/zh not_active Expired - Fee Related
- 1999-05-26 BR BR9910696-5A patent/BR9910696A/pt not_active Application Discontinuation
- 1999-05-26 EP EP99927760A patent/EP1082119B1/en not_active Expired - Lifetime
- 1999-05-26 FR FR9906629A patent/FR2779145B1/fr not_active Expired - Fee Related
- 1999-05-26 DE DE19983247T patent/DE19983247T1/de not_active Withdrawn
- 1999-05-26 SK SK1775-2000A patent/SK17752000A3/sk unknown
- 1999-05-26 DK DK99927760T patent/DK1082119T3/da active
- 1999-05-26 JP JP2000550485A patent/JP4083985B2/ja not_active Expired - Fee Related
- 1999-05-26 AU AU45008/99A patent/AU755134B2/en not_active Ceased
- 1999-05-26 WO PCT/EP1999/003623 patent/WO1999061025A1/en not_active Ceased
- 1999-05-26 ES ES99927760T patent/ES2214859T3/es not_active Expired - Lifetime
- 1999-05-26 GB GB0028506A patent/GB2353473A/en not_active Withdrawn
- 1999-05-26 HU HU0102202A patent/HUP0102202A3/hu unknown
- 1999-05-26 IT IT1999MI001164A patent/IT1313551B1/it active
- 1999-05-26 ID IDW20002316A patent/ID27096A/id unknown
- 1999-05-26 TR TR2000/03502T patent/TR200003502T2/xx unknown
- 1999-05-26 NZ NZ508325A patent/NZ508325A/xx unknown
-
2000
- 2000-11-23 NO NO20005920A patent/NO20005920L/no not_active Application Discontinuation
-
2002
- 2002-04-10 US US10/119,549 patent/US20020156099A1/en not_active Abandoned
-
2003
- 2003-03-04 US US10/379,345 patent/US6949257B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102407735B1 (ko) | 나노에멀젼 전달 시스템의 조성물 | |
| DE4308282C2 (de) | Vorzugsweise in Form von Mikrosphärulen vorliegende galenische Matrices | |
| CN106691888B (zh) | 一种高皮肤滞留光甘草定纳米组合物及其制备方法和用途 | |
| HU213669B (en) | Preparation suitable for local treatment and comprising suspension of solid lipid particles, as well as process for producing same and pharmaceutical compositions for local treatment of body | |
| US20060110418A1 (en) | Water-in-oil emulsions and methods | |
| TW201714605A (zh) | 具有可逆的連續及分散相之奈米乳液 | |
| PE20000537A1 (es) | Composicion farmaceutica dispersable que contiene antagonistas de sustancia p de piperidina | |
| RU2013145709A (ru) | Офтальмическая композиция | |
| AU2014359195A1 (en) | Lipid microcapsules preferably comprising a lipophilic active substance and composition containing same, method for the production thereof, and use of same in dermatology and in cosmetics | |
| CN102906317A (zh) | 纳米纤维 | |
| RU2010104979A (ru) | Композиция эмульсии "масло в воде" и способ ее получения | |
| NZ600999A (en) | Cutaneous composition comprising vitamin d analogue and a mixture of solvent and surfactants | |
| RU2015131700A (ru) | Фармацевтические композиции, включающие производное камптотецина | |
| TW200911301A (en) | Pharmaceutical composition for topical application of poorly soluble compounds | |
| JP2010531684A5 (es) | ||
| JP2008273881A (ja) | 多層被覆油粒子、その水分散液、及びそれらの製造方法 | |
| JP2012523408A (ja) | ジクロフェナクの安定な医薬組成物 | |
| Jaromin et al. | Azacarbazole n-3 and n-6 polyunsaturated fatty acids ethyl esters nanoemulsion with enhanced efficacy against Plasmodium falciparum | |
| Kichou et al. | Efficiency of emulsifier‐free emulsions in delivering caffeine and α‐tocopherol to human skin | |
| Khalil et al. | Influence of formulation parameters on the physicochemical properties of meloxicam-loaded solid lipid nanoparticles | |
| RU2007137182A (ru) | Микроэмульсии соединений, связывающихся с каннабиноидными рецепторами | |
| JP2008532967A5 (es) | ||
| KR100350179B1 (ko) | Sedds로 제제화한 발기부전치료용 주입액제 | |
| US20190388543A1 (en) | Formulations and methods for compositions used in wearable drug delivery devices | |
| TW200824717A (en) | Composition for external application to skin and skin regeneration promoter |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant, registration | ||
| FD | Application declared void or lapsed |